The role of gastrin 17 and pepsinogen I:pepsinogen II ratio in pathological diagnosis and endoscopic selection in gastritis patients
Laboratory Medicine · 2024
DOI: 10.1093/labmed/lmad119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Qian Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Wenzhou People's Hospital, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Pepsinogen A, Gastritis, Pepsinogen C, Gastrins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Background
The noninvasive serum markers pepsinogen I (PGI), pepsinogen II (PGII), gastrin-17 (G17), and PGI:PGII ratio (PGR) have recently been proposed as a new tool for predicting various gastric pathologies.
Methods
A total of 83 gastritis patients confirmed by gastroscopy were enrolled, with 78 undergoing concurrent colonoscopies. The control group included 99 healthy subjects. Enzyme-linked immunosorbent assay was used to detect PGI, PGII, G17, and PGR. The performance of serological analysis for detecting gastritis pathology was evaluated using receiver operating characteristic (ROC) curves.
Results
The G17 and PGII levels increased significantly (P < .001), whereas PGR levels decreased (P = .001) in the gastritis group. The ROC analysis revealed that PGR had a sensitivity and specificity of 70.83% and 86.67%, respectively, in predicting Helicobacter pylori-infected gastritis and a sensitivity and specificity of 88% and 65.52%, respectively, in predicting active gastritis. The G17 levels were significantly elevated in gastritis patients undergoing concurrent colonoscopies (P < .05).
Conclusion
Pepsinogen I:pepsinogen II ratio was found to be a useful predictor of active gastritis and H pylori-infected gastritis. Furthermore, G17 was found to be closely related to pathological conditions found by colonoscopy and may provide recommendations for whether gastritis patients should undergo a concurrent colonoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.
Förderung
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Ye, Q., Xu, K., Tong, Y., & Zhao, M. (2024). The role of gastrin 17 and pepsinogen I:pepsinogen II ratio in pathological diagnosis and endoscopic selection in gastritis patients. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad119
Vancouver
Ye Q, Xu K, Tong Y, Zhao M. The role of gastrin 17 and pepsinogen I:pepsinogen II ratio in pathological diagnosis and endoscopic selection in gastritis patients. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad119
BibTeX
@article{Ye2024,
author = {Ye, Qian and Xu, Kai and Tong, Yu and Zhao, Misheng},
title = {The role of gastrin 17 and pepsinogen I:pepsinogen II ratio in pathological diagnosis and endoscopic selection in gastritis patients},
journal = {Laboratory Medicine},
year = {2024},
doi = {10.1093/labmed/lmad119}
}
EUVIMED